Trial NCT01338857

View at ClinicalTrials.gov 
Org. Study IDs: 10-00561

Last trial update was posted on 2017-02-17

MeSH Interventions

Sorafenib

MeSH Conditions

Astrocytoma Glioma Neurofibroma Neurofibromatoses Neurofibromatosis 1 Recurrence

Other Conditions

Recurrent or Progressive Low-grade Glioma Recurrent or Progressive Optic Pathway Gliomas (OPG) neurofibromatosis1 (NF1)

Stopping Reasons

Sorafenib ineffective for tx of recurrent or progressive PLGA

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID